Nombre de documents

31

CV de Stéphanie Grandemange


Article dans une revue15 documents

  • Hugo Gattuso, Vanessa Besancenot, Stéphanie Grandemange, Marco Marazzi, Antonio Monari. From non-covalent binding to irreversible DNA lesions: nile blue and nile red as photosensitizing agents. Scientific Reports, Nature Publishing Group, 2016, 6, pp.28480. <10.1038/srep28480>. <hal-01414606>
  • Audrey Berthe, Stéphane Flament, Stéphanie Grandemange, Marie Zaffino, Michel Boisbrun, et al.. Δ2-Troglitazone promotes cytostatic rather than pro-apoptotic effects in breast cancer cells cultured in high serum conditions. Cell Cycle, Taylor & Francis, 2016, 15 (24), pp.3402-3412. <10.1080/15384101.2016.1245248>. <hal-01411104>
  • Claire Barbieux, Jalal Bacharouche, Charles Soussen, Sebastien Hupont, Angélina Razafitianamaharavo, et al.. DDB2 (damaged-DNA binding 2) protein: a new modulator of nanomechanical properties and cell adhesion of breast cancer cells. Nanoscale, Royal Society of Chemistry, 2016, 8 (9), pp.5268-5279. <http://pubs.rsc.org/en/Content/ArticleLanding/2016/NR/C5NR09126H>. <10.1039/C5NR09126H>. <hal-01283070>
  • Roudayna Diab, Anne-Sophie Virriat, Carole Ronzani, Stéphane Fontanay, Stéphanie Grandemange, et al.. Elaboration of sterically stabilized liposomes for S-nitrosoglutathione targeting to macrophages. Journal of Biomedical Nanotechnology, American Scientific Publishers, 2016, 12 (1), pp.217-230(14). <10.1166/jbn.2016.2130>. <hal-01320655>
  • Ramia Safar, Carole Ronzani, Roudayna Diab, Jérôme Chevrier, Danièle Bensoussan, et al.. Human monocyte response to S-nitrosoglutathione-loaded nanoparticles: uptake, viability, and transcriptome.. Molecular Pharmaceutics, American Chemical Society, 2015, 12 (2), pp.554-61. <10.1021/mp5006382>. <hal-01234820>
  • David Brie, Remi Klotz, Sebastian Miron, Said Moussaoui, Christian Mustin, et al.. Joint analysis of flow cytometry data and fluorescence spectra as a non-negative array factorization problem. Chemometrics and Intelligent Laboratory Systems, Elsevier, 2014, 137, pp.21-32. <10.1016/j.chemolab.2014.06.003>. <hal-01076326>
  • David Brie, Rémi Klotz, Sebastian Miron, Saïd Moussaoui, Christian Mustin, et al.. Joint analysis of flow cytometry data and fluorescence spectra as a non-negative array factorization problem. Chemometrics and Intelligent Laboratory Systems, Elsevier, 2014, 137, pp.21-32. <10.1016/j.chemolab.2014.06.003>. <hal-01020580>
  • Philippe Becuwe, Marie Ennen, Rémi Klotz, Claire Barbieux, Stéphanie Grandemange. Manganese superoxide dismutase in breast cancer: From molecular mechanisms of gene regulation to biological and clinical significance. Free Radical Biology and Medicine, Elsevier, 2014, pp.77C:139-151. <10.1016/j.freeradbiomed.2014.08.026>. <hal-01094585>
  • Marie Ennen, Remi Klotz, Nadège Touche, Sophie Pinel, Claire Barbieux, et al.. DDB2: a novel regulator of NF-κB and breast tumor invasion. Cancer Research, American Association for Cancer Research, 2013, 73 (16), pp.5040-5052. <10.1158/0008-5472.CAN-12-3655>. <hal-00921880>
  • Laurence Pessemesse, Audrey Schlernitzauer, Chamroeun Sar, Jonathan Levin, Stéphanie Grandemange, et al.. Depletion of the p43 mitochondrial T3 receptor in mice affects skeletal muscle development and activity.. FASEB Journal, Federation of American Society of Experimental Biology, 2012, 26 (2), pp.748-756. <10.1096/fj.11-195933>. <hal-00746541>
  • Housam Eidi, Olivier Joubert, Christophe Némos, Stéphanie Grandemange, Baharia Mograbi, et al.. Drug delivery by polymeric nanoparticles induces autophagy in macrophages.. International Journal of Pharmaceutics, Elsevier, 2012, 422 (1-2), pp.495-503. <10.1016/j.ijpharm.2011.11.020>. <hal-00746557>
  • Angel Carazo, Jonathan Levin, François Casas, Pascal Seyer, Stéphanie Grandemange, et al.. Protein sequences involved in the mitochondrial import of the 3,5,3'-L-triiodothyronine receptor p43.. Journal of Cellular Physiology, Wiley, 2012, 227 (12), pp.3768-3777. <10.1002/jcp.24085>. <hal-00747594>
  • Marie Ennen, Vanessa Minig, Stéphanie Grandemange, Nadège Touche, Jean-Louis Merlin, et al.. Regulation of the high basal expression of the manganese superoxide dismutase gene in aggressive breast cancer cells.. Free Radical Biology and Medicine, Elsevier, 2011, 50 (12), pp.1771-1779. <10.1016/j.freeradbiomed.2011.03.013>. <hal-00747766>
  • Pascal Seyer, Stéphanie Grandemange, Pierrick Rochard, Muriel Busson, Laurence Pessemesse, et al.. P43-dependent mitochondrial activity regulates myoblast differentiation and slow myosin isoform expression by control of Calcineurin expression.. Experimental Cell Research, Elsevier, 2011, 317 (14), pp.2059-2071. <10.1016/j.yexcr.2011.05.020>. <hal-00747781>
  • Francois Casas, Laurence Pessemesse, Stephanie Grandemange, Pascal Seyer, Naig Gueguen, et al.. Overexpression of the Mitochondrial T3 Receptor p43 Induces a Shift in Skeletal Muscle Fiber Types. PLoS ONE, Public Library of Science, 2008, 3 (6), <10.1371/journal.pone.0002501>. <hal-01189356>

Communication dans un congrès12 documents

  • Claire Barbieux, Grégory Francius, Rémi Klotz, Vanessa Besancenot, Emilie Brunner, et al.. The transcriptional regulator DDB2 modulates TGFβ1 signaling and membrane nanomechanics of breast cancer cells. 2nd International Symposium of the Cancer Research Center of Lyon, CRCL 2015, Sep 2015, Lyon, France. <hal-01246679>
  • Audrey Berthe, Stéphanie Grandemange, Michel Boisbrun, Bost Frédéric, Marie Zaffino, et al.. Delta-2-Troglitazone targets mitochondria in triple-negative breast cancer cells: a metabolic change contributing to sensitization of cancer cells to chemotherapy? . 9e Forum du Cancéropôle Grand Est , Nov 2015, Strasbourg, France. <hal-01243561>
  • Claire Barbieux, Grégory Francius, Rémi Klotz, Vanessa Besancenot, Emilie Brunner, et al.. The Damaged DNA Binding 2 protein: a new modulator of TGFβ1 signaling pathway and membrane nanomechanics in breast cancer cells. 40th Congress of The Federation of European Biochemical Societies, FEBS 2015, Jul 2015, Berlin, Germany. FEBS Journal, 282 (S1), pp.36, 2015, Special Issue: 40th FEBS Congress. <10.1111/febs.13320>. <hal-01246673>
  • Claire Barbieux, Grégory Francius, Rémi Klotz, Vanessa Besancenot, Emilie Brunner, et al.. The Damaged DNA Binding 2 protein: a new modulator of TGFβ-1 signaling pathway and membrane nanomechanics in breast cancer cells. La journée des doctorants Lorrains : DocSciLor 2015, Jun 2015, Nancy, France. <hal-01246682>
  • Claire Barbieux, Grégory Francius, Rémi Klotz, Marie Ennen, Vanessa Besancenot, et al.. The transcriptional regulator DDB2 modulates TGF beta 1 signaling and cell adhesion in breast cancer cells. 8ème forum du Cancéropôle Grand-Est, Nov 2014, Strasbourg, France. <hal-01100733>
  • David Brie, Sebastian Miron, Philippe Becuwe, Stéphanie Grandemange. A non-negative multilinear block tensor decomposition approach to flow cytometry data analysis. 24th IEEE International Workshop on Machine Learning for Signal Processing, MLSP 2014, Sep 2014, Reims, France. <hal-01082335>
  • Rémi Klotz, Vanessa Besancenot, Emilie Brunner, Philippe Becuwe, Stéphanie Grandemange. DDB2, a new regulator of metabolism and cell death in human breast tumor cells. 35th San Antonio Breast Cancer Symposium, CTRC-AACR 2012, Dec 2012, San Antonio, Texas, United States. pp.CDROM, 2012. <hal-00747606>
  • Rémi Klotz, Marie Ennen, Vanessa Besancenot, Emilie Brunner, Nadège Touche, et al.. La protéine DDB2 un nouveau régulateur du métabolisme et de la mort cellulaire dans les cellules cancéreuses mammaires. 7ème Journée Claude HURIET de Recherche Biomédicale du CHU & Faculté de Médecine de Nancy, Mar 2012, Vandoeuvre-les-Nancy, France. <hal-00747753>
  • Marie Ennen, Stéphanie Grandemange, Sophie Pinel, François Plénat, Nadège Touche, et al.. La protéine Damaged DNA Binding 2 : un candidat prometteur dans la prédiction de la progression métastatique des tumeurs mammaires. 7ème Journée Claude HURIET de Recherche Biomédicale du CHU & Faculté de Médecine de Nancy, Mar 2012, Vandoeuvre-les-Nancy, France. <hal-00747754>
  • Rémi Klotz, Vanessa Besancenot, Emilie Brunner, Stéphanie Grandemange, Philippe Becuwe. DDB2, a new regulator of mitochondrial metabolism and sensitivity to cell death in human breast tumor cells. 2ème Colloque Inter-régional Grand-Est de Recherche Translationnelle en Oncologie, ONCOTRANS 2011, Sep 2011, Nancy, France. <hal-00747857>
  • Marie Ennen, Stéphanie Grandemange, Nadège Touche, Muriel Barberi-Heyob, Philippe Becuwe. Role of the Damaged DNA-Binding 2 protein in the tumor progression through its control on the Nuclear Factor-kappa B activation in breast tumor cells.. 102nd Annual Meeting of the American Association of Cancer Research, Apr 2011, Orlando, Florida, United States. pp.CDROM, 2011. <hal-00747777>
  • Marie Ennen, Sophie Pinel, Emilie Brunner, Vanessa Besancenot, Nadège Touche, et al.. The Damaged DNA-Binding 2 (DDB2) protein plays a role in the invasive properties of breast tumor cells through its control on the Nuclear Factor-kappa B activation. 2ème Colloque Inter-régional Grand-Est de Recherche Translationnelle en Oncologie, ONCOTRANS 2011, Sep 2011, Nancy, France. <hal-00747863>

Chapitre d'ouvrage1 document

  • Thibaut Roux-Marchand, Denis Beyssen, Frederic Sarry, Stéphanie Grandemange, Omar Elmazria. Rayleigh surface acoustic wave compatibility with microdroplet polymerase chain reaction. Lixin Cheng. Mechanical Engineering Theory and Applications, 4 (3/4), Nova Science Publishers, pp.225-242, 2015, 978-1-63463-983-5. <hal-01292305>

Rapport1 document

  • David Brie, Rémy Klotz, Sébastian Miron, Saïd Moussaoui, Christian Mustin, et al.. Joint Analysis of Flow Cytometry Data and Fluorescence Spectra as a Non-Negative Array Factorization Problem. 2014. <hal-00990043>

Poster2 documents

  • Audrey Berthe, Stéphanie Grandemange, Michel Boisbrun, Bost Frédéric, Marie Zaffino, et al.. Delta-2-troglitazone sensitizez triple-negative breast cancer cells to chemotherapy: a consequence of mitochondrial dysfunction?. 6th World Congress on Targeting Mitochondria, Oct 2015, Berlin, Germany. 2015. <hal-01214922>
  • Audrey Berthe, Stéphanie Grandemange, Michel Boisbrun, Bost Frédéric, Stéphane Flament, et al.. D2-Troglitazone alters energetic metabolism in triple-negative breast cancer cells: a mechanism to sensitize cancer cells to chemotherapy? . Cancer and Metabolism conference, 2015, Sep 2015, Cambridge, United Kingdom. <http://www.abcam.com/events/cancer-and-metabolism-conference-2015>. <hal-01214915>